Pathophysiological power of improper tonic GABAAconductances in mature and immature models

Frontiers in Neural Circuits

Volumn 7, Issue OCT, 2013, Pages

  Egawa, Kiyoshi ^a,b   Fukuda, Atsuo ^c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Ambient; Extrasynaptic; Gaba; GABAA; Gat; Neurological disease; Receptor; Tonic inhibition; Transporter

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; GABAERGIC RECEPTOR AFFECTING AGENT; GABOXADOL; PICROTOXININ; RO 4938581; UNCLASSIFIED DRUG; 4 AMINOBUTYRIC ACID;

ARTICLE; AUTISM; BRAIN REGION; CELL FUNCTION; CENTRAL NERVOUS SYSTEM DISEASE; CEREBROVASCULAR ACCIDENT; COGNITION; CONVALESCENCE; DEVELOPMENTAL DISORDER; DISORIENTATION; DOWN SYNDROME; DRUG MECHANISM; DRUG SAFETY; EPILEPSY; HALLUCINATION; HUMAN; MENTAL DISEASE; MOTOR DYSFUNCTION; NERVE EXCITABILITY; NERVOUS SYSTEM CONDUCTANCE; NERVOUS SYSTEM DEVELOPMENT; NEUROMODULATION; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; SYNAPTIC INHIBITION; AMBIENT; ANIMAL; EXTRASYNAPTIC; GABAA RECEPTOR; GAT; HIPPOCAMPUS; METABOLISM; NERVE CELL; NERVE CELL INHIBITION; NERVE CONDUCTION; NEUROLOGIC DISEASE; PHYSIOLOGY; REVIEW; TONIC INHIBITION; TRANSPORTER;

AMBIENT; EXTRASYNAPTIC; GABA; GABAA RECEPTOR; GAT; NEUROLOGICAL DISEASE; TONIC INHIBITION; TRANSPORTER;

ANIMALS; GAMMA-AMINOBUTYRIC ACID; HIPPOCAMPUS; NEURAL CONDUCTION; NEURAL INHIBITION; NEURONS; RECEPTORS, GABA-A;

EID: 84888183031     PISSN: 16625110     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncir.2013.00170     Document Type: Article

References (178)

1. Ade, K. K., Janssen, M. J., Ortinski, P. I., and Vicini, S. (2008). Differential tonic GABA conductances in striatal medium spiny neurons. J. Neurosci. 28, 1185-1197. doi: 10.1523/JNEUR0SCI.3908-07.2008
2. Adusei, D. C., Pacey, L. K., Chen, D., and Hampson, D. R. (2010). Early developmental alterations in GABAergic protein expression in fragile X knockout mice. Neuropharmacology 59, 167-171. doi: 10.1016/j.neuropharm.2010.05.002
3. A receptor subunit gene expression in human prefrontal cortex: comparison of schizophrenics and controls. Cereb. Cortex 5, 550-560. doi: 10.1093/cer- cor/5.6.550
4. Akbarian, S., Kim, J. J., Potkin, S. G., Hagman, J. O., Tafazzoli, A., Bunney, W. E., et al. (1995b). Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch. Gen. Psychiatry 52, 258-266. doi: 10.1001/arch- psyc.1995.03950160008002
5. A receptor regulation of stem cell proliferation. Nature 451, 460-464. doi: 10.1038/nature06488
6. A receptor a4 and 5 subunits at the plasma membrane of hippocampal CA1 spines. Synapse 66, 391-407. doi: 10.1002/syn.21528
7. A/Benzodiazepine receptor binding in patients with schizophrenia using [11C]Ro15- 4513, a radioligand with relatively high affinity for a5 subunit. Schizophr. Res. 99, 333-340. doi: 10.1016/j.schres.2007.10.014
8. A receptor a5 subtype- selective inverse agonist α5IA. Pharmacol. Ther. 125, 11-26. doi: 10.1016/j.pharmthera.2009.09.001
9. A receptors. Neuropharmacology 51, 1023-1029. doi: 10.1016/j.neuropharm.2006.04.018
10. A receptor a5 subtype-selective inverse agonist. J. Pharmacol. Exp. Ther. 331, 470-484. doi: 10.1124/jpet.109.157636
11. A a5 subunit-containing receptors. Psychopharmacol ogy (Berl.) 202, 207-223. doi: 10.1007/s00213-008-1357-7
12. Bassell, G. J., and Warren, S. T. (2008). Fragile X syndrome: loss of local mRNA regulation alters synaptic development and function. Neuron 60, 201-214. doi: 10.1016/j.neuron.2008.10.004
13. Behar, T. N., Li, Y. X., Tran, H. T., Ma, W., Dunlap, V., Scott, C., et al. (1996). GABAstimulates chemotaxis, and chemokinesis of embryonic cortical neurons via calcium-dependent mechanisms. J. Neurosci. 16, 1808-1818.
14. Behar, T. N., Schaffner, A. E., Scott, C. A., Greene, C. L., and Barker, J. L. (2000). GABA receptor antagonists modulate postmitotic cell migration in slice cultures of embryonic rat cortex. Cereb. Cortex 10, 899-909. doi: 10.1093/cercor/10.9.899
15. Behar, T. N., Schaffner, A. E., Scott, C. A., O'Connell, C., and Barker, J. L. (1998). Differential response of cortical plate and ventricular zone cells to GABA as a migration stimulus. J. Neurosci. 18, 6378-6387.
16. Behar, T. N., Smith, S. V., Kennedy, R. T., McKenzie, J. M., Maric, I., and Barker, J.L. (2001). GABAb receptors mediate motility signals for migrating embryonic cortical cells. Cereb. Cortex 11, 744-753. doi: 10.1093/cer- cor/11.8.744
17. Belichenko, P. V., Kleschevnikov, A. M., Masliah, E., Wu, C., Takimoto- Kimura, R., Salehi, A., et al. (2009). Excitatory-inhibitory relationship in the fascia dentata in the Ts65Dn mouse model of Down syndrome. J. Comp. Neurol. 512, 453-466. doi: 10.1002/cne.21895
18. Ben-Ari, Y. (2002). Excitatory actions of GABA during development: the nature of the nurture. Nat. Rev. Neurosci. 3, 728-739. doi: 10.1038/nrn920
19. Ben-Ari, Y., Gaiarsa, J. L., Tyzio, R., and Khazipov, R. (2007). GABA: a pioneer transmitter that excites immature neurons and generates primitive oscillations. Physiol. Rev. 87, 1215-1284. doi: 10.1152/phys- rev.00017.2006
20. A receptor channels from low- to high- efficacy gating patterns. J. Neurosci. 23, 10934-10943.
21. A receptors that generate a tonic inhibitory conductance in spinal neurons attenuates acute nociception in mice. Pain 152, 1317-1326. doi: 10.1016/j.pain.2011.02.011
22. Bortone, D., and Polleux, F. (2009). KCC2 expression promotes the termination of cortical interneuron migration in a voltage- sensitive calcium-dependent manner. Neuron 62, 53-71. doi: 10.1016/j.neuron.2009.01.034
23. Braudeau, J., Delatour, B., Duchon, A., Pereira, P. L., Dauphinot, L., De Chaumont, F., et al. (2011). Specific targeting of the GABA-A receptor α5 subtype by a selective inverse agonist restores cognitive deficits in Down syndrome mice. J. Psychopharmacol. 25, 1030-1042. doi: 10.1177/0269881111405366
24. A receptors. J. Physiol. 497, 753-759.
25. A receptors: their function in the CNS and implications for disease. Neuron 73, 23-34. doi: 10.1016/j.neuron.2011.12.012
26. Brickley, S. G., Revilla, V., Cull- Candy, S. G., Wisden, W., and Farrant, M. (2001). Adaptive regulation of neuronal excitability by a voltage-independent potassium conductance. Nature 409, 88-92. doi: 10.1038/35051086
27. A receptors during spillover. J. Neurosci. 31, 753-763. doi: 10.1523/JNEUROSCI.2996-10.2011
28. Brunig, I., Scotti, E., Sidler, C., and Fritschy, J. M. (2002). Intact sorting, targeting, and clustering of y-aminobutyric acidA receptor subtypes in hippocampal neurons in vitro. J. Comp. Neurol. 443, 43-55. doi: 10.1002/cne.10102
29. A receptor subunits in rat brainstem auditory pathways: cochlear nuclei, superiorolivarycomplexandnucleus of the lateral lemniscus. Neuroscience 102, 625-638. doi: 10.1016/S0306- 4522(00)00525-X
30. Caraiscos, V. B., Elliott, E. M., You- Ten, K. E., Cheng, V. Y., Belelli, D., Newell, J. G., et al. (2004). Tonic inhibition in mouse hippocampal CA1 pyramidal neurons is mediated by a5 subunit-containing y-aminobutyric acid type A receptors. Proc. Natl. Acad. Sci. U.S.A. 101, 3662-3667. doi: 10.1073/pnas.0307231101
31. Carlesimo, G. A., Marotta, L., and Vicari, S. (1997). Long-term memory in mental retardation: evidence for a specific impairment in subjects with Down's syndrome. Neuropsychologia 35, 71-79. doi: 10.1016/S0028- 3932(96)00055-3
32. A receptor a 4 subunits mediate extrasy- naptic inhibition in thalamus and dentate gyrus and the action of gaboxadol. Proc. Natl. Acad. Sci. U.S.A. 103, 15230-15235. doi: 10.1073/pnas.0604304103
33. Chao, H. T., Chen, H., Samaco, R. C., Xue, M., Chahrour, M., Yoo, J., et al. (2010). Dysfunction in GABA signalling mediates autismlike stereotypies and Rett syndrome phenotypes. Nature 468, 263-269. doi: 10.1038/nature09582
34. Chiu, C. S., Brickley, S., Jensen, K., Southwell, A., McKinney, S., Cull-Candy, S., et al. (2005). GABA transporter deficiency causes tremor, ataxia, nervousness, and increased GABA-induced tonic conductance in cerebellum. J. Neurosci. 25, 3234-3245. doi: 10.1523/JNEUROSCI.3364-04.2005
35. Clarkson, A. N., Huang, B. S., MacIsaac, S. E., Mody, I., and Carmichael, S. T. (2010). Reducing excessive GABA-mediated tonic inhibition promotes functional recovery after stroke. Nature 468, 305-309. doi: 10.1038/nature09511
36. Coghlan, S., Horder, J., Inkster, B., Mendez, M. A., Murphy, D. G., and Nutt, D. J. (2012). GABA system dysfunction in autism and related disorders: from synapse to symptoms. Neurosci. Biobe- hav. Rev. 36, 2044-2055. doi: 10.1016/j.neubiorev.2012.07.005
37. A receptor. J. Neurosci. 22, 5572-5580.
38. A inhibition in typical absence epilepsy. Nat. Med. 15, 1392-1398. doi: 10.1038/nm.2058
39. A receptor-mediated tonic inhibition in thalamic neurons. J. Neurosci. 25, 11553-11563. doi: 10.1523/JNEUROSCI.3362-05.2005
40. A receptors. Proc. Natl. Acad. Sci. U.S.A. 99, 8980-8985. doi: 10.1073/pnas.142288699
41. Curia, G., Papouin, T., Seguela, P., and Avoli, M. (2009). Downregulation of tonic GABAergic inhibition in a mouse model of fragile X syndrome. Cereb. Cortex 19, 1515-1520. doi: 10.1093/cercor/bhn159
42. A receptor subunit profiles of tangentially migrating neurons derived from the medial ganglionic eminence. Cereb. Cortex 21, 1792-1802. doi: 10.1093/cercor/bhq247
43. Cuzon, V. C., Yeh, P. W., Cheng, Q., and Yeh, H. H. (2006). Ambient GABA promotes cortical entry of tangentially migrating cells derived from the medial ganglionic eminence. Cereb. Cortex 16, 1377-1388. doi: 10.1093/cercor/bhj084
44. A receptor activation reverses recognition memory deficits in an animal model of schizophrenia. Psychopharmacology 214, 403-413. doi: 10.1007/s00213-010-2039-9
45. A receptor subunit. Nature 385, 820-823. doi: 10.1038/385820a0
46. A receptors enhances cognition. J. Pharmacol. Exp. Ther. 316, 1335-1345. doi: 10.1124/jpet.105.092320
47. De Biasi, S., Vitellaro-Zuccarello, L., and Brecha, N. C. (1998). Immunore- activity for the GABA transporter-1 and GABA transporter-3 is restricted to astrocytes in the rat thalamus. A light and electron-microscopic immunolocalization. Neuroscience 83, 815-828. doi: 10.1016/S0306- 4522(97)00414-4
48. 2+ and SNARE-independent release of GABA and glutamate prior to synapse formation. Neuron 36, 1051-1061. doi: 10.1016/S0896-6273(02)01053-X
49. Denter, D. G., Heck, N., Riedemann, T., White, R., Kilb, W., and Luhmann, H. J. (2010). GABAc receptors are func- tionallyexpressed in the intermediate zone and regulate radial migration in the embryonic mouse neocortex. Neuroscience 167, 124-134. doi: 10.1016/j.neuroscience.2010.01.049
50. de Villers-Sidani, E., Alzghoul, L., Zhou, X., Simpson, K. L., Lin, R.C., and Merzenich, M. M. (2010). Recovery of functional and structural age-related changes in the rat primary auditory cortex with operant training. Proc. Natl. Acad. Sci. U.S.A. 107, 13900-13905. doi: 10.1073/pnas.1007885107
51. Diaz, M. R., Wadleigh, A., Hughes, B.A., Woodward, J. J., and Valenzuela, C.F. (2011). Bestrophin1 channels are insensitive to ethanol and do not mediate tonic GABAergic currents in cerebellar granule cells. Front. Neurosci. 5:148. doi: 10.3389/fnins.2011.00148
52. Dictenberg, J. B., Swanger, S. A., Antar, L. N., Singer, R. H., and Bassell, G. J. (2008). A direct role for FMRP in activity-dependent dendritic mRNA transport links filopodial-spine morphogenesis to fragile X syndrome. Dev. Cell 14, 926-939. doi: 10.1016/j.devcel.2008.04.003
53. Di Martino, A., and Tuchman, R. F. (2001). Antiepileptic drugs: affective use in autism spectrum disorders. Pediatr. Neurol. 25, 199-207. doi: 10.1016/S0887-8994(01)00276-4
54. Dvorak, K., and Feit, J. (1977). Migration of neuroblasts through partial necrosis of the cerebral cortex in newborn rats-contribution to the problems of morphological development and developmental period of cerebral microgyria. Histological and autoradiographical study. Acta Neuropathol. 38, 203-212. doi: 10.1007/BF00688066
55. Egawa, K., Asahina, N., Shi- raishi, H., Kamada, K., Takeuchi, F., Nakane, S., et al. (2008). Aberrant somatosensory-evoked responses imply GABAergic dysfunction in Angelman syndrome. Neuroimage 39, 593-599. doi: 10.1016/j.neuroimage.2007.09.006
56. Egawa, K., Kitagawa, K., Inoue, K., Takayama, M., Takayama, C., Saitoh, S., et al. (2012). Decreased tonic inhibition in cerebellar granule cells causes motor dysfunction in a mouse model of Angelman syndrome. Sci. Transl. Med. 4, 163ra157.
57. - homeodynamics in gap-junction-coupled astrocytic networks on activation of GABAergic synapses. J. Physiol. 591(Pt. 16), 3901-3917. doi: 10.1113/jphys- iol.2013.257162
58. A receptor expression in the seizure-prone fragile X mouse. Neu- rosci. Lett. 377, 141-146. doi: 10.1016/j.neulet.2004.11.087
59. Enna, S. J., and McCarson, K. E. (2006). The role of GABA in the mediation and perception of pain. Adv. Pharmacol. 54, 1-27. doi: 10.1016/S1054- 3589(06)54001-3
60. Ewers, M., Sperling, R. A., Klunk, W. E., Weiner, M. W., and Hampel, H. (2011). Neuroimaging markers for the prediction and early diagnosis of Alzheimer's disease dementia. Trends Neurosci. 34, 430-442. doi: 10.1016/j.tins.2011.05.005
61. A receptors. Nat. Rev. Neurosci. 6, 215-229. doi: 10.1038/nrn1625
62. Francis, F., Meyer, G., Fallet-Bianco, C., Moreno, S., Kappeler, C., Socorro, A. C., et al. (2006). Human disorders of cortical development: from past to present. Eur. J. Neurosci. 23, 877-893. doi: 10.1111/j.1460- 9568.2006.04649.x
63. A-receptor subtypes during postnatal development: an immunohistochemical study. J. Neurosci. 14, 5302-5324.
64. Fukuda, A., and Wang, T. (2013).Aper- turbation of multimodal GABA functions underlying the formation of focal cortical malformations: assessments by using animal models. Neuropathology 33, 480-486. doi: 10.1111/neup.12021
65. AR-positive allosteric modulator reverses hyperactivation of the dopamine system in the MAM model of schizophrenia. Neuropsychopharmacology 36, 1903-1911. doi: 10.1038/npp.2011.76
66. Gleich, O., Hamann, I., Klump, G. M., Kittel, M., and Strutz, J. (2003). Boosting GABA improves impaired auditory temporal resolution in the gerbil. Neuroreport 14, 1877-1880. doi: 10.1097/01.wnr.0000089569.45990.74
67. A receptor α5 subunit-deficient mice. J. Neurophysiol. 95, 2796-2807. doi: 10.1152/jn.01122.2005
68. Glykys, J., and Mody, I. (2007). The main source of ambient GABA responsible for tonic inhibition in the mouse hippocampus. J. Physiol. 582, 1163-1178. doi: 10.1113/jphys- iol.2007.134460
69. Guidotti, A., Auta, J., Davis, J. M., Dong, E., Grayson, D. R., Veldic, M., et al. (2005). GABAergic dysfunction in schizophrenia: new treatment strategies on the horizon. Psychopharmacology 180, 191-205. doi: 10.1007/s00213-005-2212-8
70. Hamann, M., Rossi, D. J., andAttwell, D. (2002). Tonic and spillover inhibition of granule cells control information flow through cerebellar cortex. Neuron 33, 625-633. doi: 10.1016/S0896- 6273(02)00593-7
71. Hashimoto, T., Volk, D. W., Eggan, S. M., Mirnics, K., Pierri, J. N., Sun, Z., et al. (2003). Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia. J. Neurosci. 23, 6315-6326.
72. Haydar, T. F., Wang, F., Schwartz, M. L., and Rakic, P. (2000). Differential modulation of proliferation in the neocortical ventricular and sub- ventricular zones. J. Neurosci. 20, 5764-5774.
73. Heck, N., Kilb, W., Reiprich, P., Kubota, H, Furukawa, T., Fukuda, A., et al. (2007). GABA-A receptors regulate neocortical neuronal migration in vitro and in vivo. Cereb. Cortex 17, 138-148. doi: 10.1093/cercor/bhj135
74. Heja, L., Nyitrai, G., Kekesi, O., Dobolyi, A., Szabo, P., Fiath, R., et al. (2012). Astrocytes convert network excitation to tonic inhibition of neurons. BMC Biol. 10:26. doi: 10.1186/17417007-10-26
75. Hewitt, S. A., Wamsteeker, J. I., Kurz, U., and Bains, J. S. (2009). Altered chloride homeostasis removes synaptic inhibitory constraint of the stress axis. Nat. Neurosci. 12, 438-443. doi: 10.1038/nn.2274
76. A receptors in nervous system pathologies. Curr. Opin. Neurobiol. 22, 552-558. doi: 10.1016/j.conb.2011.10.007
77. A receptors. Neuropharmacology 58,702-711. doi: 10.1016/j.neuropharm.2009.12.023
78. A receptor genes are normally biallelically expressed in brain yet are subject to epigenetic dysregulation in autism-spectrum disorders. Hum. Mol. Genet. 16, 691-703. doi: 10.1093/hmg/ddm014
79. Imbrosci, B., Neubacher, U., White, R., Eysel, U. T., and Mittmann, T. (2012). Shift from phasic to tonic GABAergic transmission following laser-lesions in the rat visual cortex. PflugersArch. 465, 879-893. doi: 10.1007/s00424- 012-1191-y
80. Impagnatiello, F., Guidotti, A. R., Pesold, C., Dwivedi, Y., Carun- cho, H., Pisu, M. G., et al. (1998). A decrease of reelin expression as a putative vulnerability factor in schizophrenia. Proc. Natl. Acad. Sci. U.S.A. 95, 15718-15723. doi: 10.1073/pnas.95.26.15718
81. Inada, H., Watanabe, M., Uchida, T., Ishibashi, H., Wake, H., Nemoto, T., et al. (2011). GABA regulates the multidirectional tangential migration of GABAergic interneurons in living neonatal mice. PLoS ONE 6:e27048. doi: 10.1371/jour- nal.pone.0027048
82. - homeostasis via the with-no-lysine (WNK) protein kinase signaling pathway. J. Biol. Chem. 287, 20839-20850. doi: 10.1074/jbc.M111.319418
83. A a1 and β2/3 subunits in the pre- frontal cortex of subjects with schizophrenia and bipolar disorder. Neurosci. Res. 50, 77-84. doi: 10.1016/j.neures.2004.06.006
84. A receptors. Br. J. Pharmacol. 168, 1118-1132. doi: 10.1111/bph.12001
85. Jevtovic-Todorovic, V., Hartman, R. E., Izumi, Y., Benshoff, N. D., Dikranian, K., Zorumski, C. F., et al. (2003). Earlyexposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits. J. Neurosci. 23, 876-882.
86. Jiang, Y. H., Armstrong, D., Albrecht, U., Atkins, C. M., Noebels, J. L., Eichele, G., et al. (1998). Mutation of the Angelman ubiquitin ligase in mice causes increased cytoplasmic p53 and deficits of contextual learning and long-term potentiation. Neuron 21, 799-811. doi: 10.1016/ S0896-6273(00)80596-6
87. Kaneda, M., Farrant, M., and Cull- Candy, S. G. (1995). Whole-cell and single-channel currents activated by GABA and glycine in granule cells of the rat cerebellum. J. Physiol. 485(Pt 2), 419-435.
88. A receptor subunits on hippocampal pyramidal cells by freeze- fracture replica immunolabelling. Eur. J. Neurosci. 32, 1868-1888. doi: 10.1111/j.1460-9568.2010.07473.x
89. Kennedy, R. T., Thompson, J. E., and Vickroy, T. W. (2002). In vivo monitoring of amino acids by direct sampling of brain extracellular fluid at ultralow flow rates and capillary electrophoresis. J. Neurosci. Methods 114, 39-49. doi: 10.1016/S0165- 0270(01)00506-4
90. Kersante, F., Rowley, S. C., Pavlov A., Gutierrez-Mecinas, M., Semyanov, A., Reul, J. M., et al. (2013). A functional role for both y-aminobutyric acid (GABA) transporter-1 and GABA transporter-3 in the modulation of extracellular GABA and GABAergic tonic conductances in the rat hippocampus. J. Physiol. 591, 2429-2441. doi: 10.1113/jphys- iol.2012.246298
91. Kishino, T., Lalande, M., and Wagstaff, J. (1997). UBE3A/E6- AP mutations cause Angelman syndrome. Nat. Genet. 15, 70-73. doi: 10.1038/ng0197-70
92. Kleschevnikov, A. M., Belichenko, P. V., Villar, A. J., Epstein, C. J., Malenka, R. C., and Mobley, W. C. (2004). Hippocampal long-term potentiation suppressed by increased inhibition in the Ts65Dn mouse, a genetic model of Down syndrome. J. Neurosci. 24, 8153-8160. doi: 10.1523/JNEUR0SCI.1766-04.2004
93. A a5 positive allosteric modulators improve cognitive function in aged rats with memory impairment. Neuropharmacology 64,145-152. doi: 10.1016/j.neuropharm.2012.06.023
94. A agonists and partial agonists: THIP (gaboxadol) as a non-opioid analgesic and a novel type of hypnotic. Biochem. Pharmacol. 68, 1573-1580. doi: 10.1016/j.bcp.2004.06.040
95. Krook-Magnuson, E. I., Li, P., Paluszkiewicz, S. M., and Huntsman, M. M. (2008). Tonically active inhibition selectively controls feedforward circuits in mouse barrel cortex. J. Neurophysiol. 100, 932-944. doi: 10.1152/jn.01360.2007
96. Kudielka, B. M., and Kirschbaum, C. (2005). Sex differences in HPA axis responses to stress: a review. Biol. Psychol. 69, 113-132. doi: 10.1016/j.biopsycho.2004.11.009
97. Labarrera, C., London, M., and Angelo, K. (2013). Tonic inhibition sets the state of excitability in olfactory bulb granule cells. J. Physiol. 591, 1841-1850. doi: 10.1113/jphys- iol.2012.241851
98. A receptors. Prog. Neurobiol. 71, 67-80. doi: 10.1016/j.pneurobio.2003.09.001
99. A receptor subunit mRNAs in the rat brain. III. Embryonic and postnatal development. J. Neurosci. 12, 4151-4172.
100. Lee, S., Yoon, B. E., Berglund, K., Oh, S. J., Park, H., Shin, H. S., et al. (2010). Channel-mediated tonic GABA release from glia. Science 330, 790-796. doi 10.1126/sci- ence.1184334
101. Lewis, D. A., Hashimoto, T., and Volk, D.W. (2005). Cortical inhibitory neurons and schizophrenia. Nat. Rev. Neurosci. 6, 312-324. doi: 10.1038/nrn1648
102. Lewis, D. A., Volk, D. W., and Hashimoto, T. (2004). Selective alterations in prefrontal cortical GABA neurotransmission in schizophrenia: a novel target for the treatment of working memory dysfunction. Psychopharmacology 174, 143-150. doi: 10.1007/s00213-003-1673-x
103. Liu, Z., Neff, R. A., and Berg, K. (2006). Sequential interplay of nicotinic and GABAergic signaling guides neuronal development. Science 314, 1610-1613. doi: 10.1126/science.1134246
104. Loepke, A. W., Istaphanous, G. K., McAuliffe, J. J. III, Miles, L., Hughes, E.A., McCann, J. C., et al. (2009). The effects of neonatal isoflurane exposure in mice on brain cell viability, adult behavior, learning, and memory. Anesth. Analg. 108, 90-104. doi: 10.1213/ane.0b013e31818cdb29
105. Lopez-Bendito, G., Lujan, R., Shige- moto, R., Ganter, P., Paulsen, O., and Molnar, Z. (2003). Blockade of GABAB receptors alters the tangential migration of cortical neurons. Cereb. Cortex 13, 932-942. doi: 10.1093/cer- cor/13.9.932
106. Lossie, A. C., Whitney, M. M., Ami- don, D., Dong, H. J., Chen, P., Theriaque, D., et al. (2001). Distinct phenotypes distinguish the molecular classes of Angelman syndrome. J. Med. Genet. 38, 834-845. doi: 10.1136/jmg.38.12.834
107. LoTurco, J. J., Owens, D. F., Heath, M. J., Davis, M. B., and Kriegstein, A. R. (1995). GABA and glutamate depolarize cortical progenitor cells and inhibit DNA synthesis. Neuron 1287-1298. doi: 10.1016/0896- 6273(95)90008-X
108. A receptor α4, β1, and γ1 subunits in the proliferative zone of the embryonic rat central nervous system. J. Neurosci. 15, 2547-2560.
109. AR plasticity during pregnancy: relevance to postpartum depression. Neuron 59, 207-213. doi: 10.1016/j.neuron.2008.06.019
110. A receptors mediating tonic inhibition alter seizure susceptibility and anxiety. Nat. Neurosci. 8, 797-804. doi: 10.1038/nn1469
111. Maldonado-Aviles, J. G., Curley, A. A., Hashimoto, T., Morrow, A. L., Ramsey, A. J., O'Donnell, P., et al. (2009). Altered markers of tonic inhibition in the dorsolateral prefrontal cortex of subjects with schizophrenia. Am. J. Psychiatry 166, 450-459. doi: 10.1176/appi.ajp.2008.081 01484
112. Manent, J. B., Demarque, M., Jor- quera, I., Pellegrino, C., Ben-Ari, Y., Aniksztejn, L., et al. (2005). A non- canonical release of GABA and glutamate modulates neuronal migration. J. Neurosci. 25, 4755-4765. doi: 10.1523/JNEUROSCI.0553-05.2005
113. Marin, O., and Rubenstein, J. L. R. (2001). A long, remarkable journey: tangential migration in the telencephalon. Nat. Rev. Neurosci. 2, 780-790. doi: 10.1038/35097509
114. A a5 receptor-mediated inhibition rescues functional and neuromorphological deficits in a mouse model of Down syndrome. J. Neurosci. 33, 3953-3966. doi: 10.1523/JNEUROSCI.1203-12.2013
115. A receptor subunit cluster and association to autism. Am. J. Med. Genet. B Neuropsychiatr. Genet. 131B, 51-59. doi: 10.1002/ajmg.b.30038
116. Meguro-Horike, M., Yasui, D. H., Powell, W., Schroeder, D. I., Oshimura, M., Lasalle, J. M., et al. (2011). Neuron-specific impairment of inter-chromosomal pairing and transcription in a novel model of human 15q-duplication syndrome. Hum. Mol. Genet. 20, 3798-3810. doi: 10.1093/hmg/ddr298
117. Miyashiro, K. Y., Beckel-Mitchener, A., Purk, T. P., Becker, K. G., Barret, T., Liu, L., et al. (2003). RNA cargoes associating with FMRP reveal deficits in cellular functioning in Fmr1 null mice. Neuron 37, 417-431. doi: 10.1016/S0896-6273(03)00034-5
118. A receptors. Trends Neurosci. 27, 569-575. doi: 10.1016/j.tins.2004.07.002
119. Mohler, H., Fritschy, J. M., and Rudolph, U. (2002). A new benzodiazepine pharmacology. J. Pharmacol. Exp. Ther. 300, 2-8. doi: 10.1124/jpet.300.1.2
120. Momosaki, S., Hosoi, R., Abe, K., and Inoue, O. (2010). Remarkable selectivity of the in vivo binding of [3H]Ro15-4513to a5 subtype of ben- zodiazepine receptor in the living mouse brain. Synapse 64, 928-936. doi: 10.1002/syn.20812
121. Morishima, T., Uematsu, M., Furukawa, T., Yanagawa, Y., Fukuda, A., and Yoshida, S. (2010). GABA imaging in brain slices using immobilized enzyme-linked photo analysis. Neurosci. Res. 67, 347-353. doi: 10.1016/j.neures.2010.04.005
122. A receptors on rat hippocampal pyramidal neurons. J. Physiol. 577, 841-856. doi: 10.1113/jphys- iol.2006.117952
123. ;-[5-(1-hydroxy-1-methyl-ethyl)- benzoimidazol-1-yl]-biphenyl- 2-carbonitrile] with diazepam, zolpidem, bretazenil, and gabox- adol in rat models of inflammatory and neuropathic pain. J. Pharmacol. Exp. Ther. 327, 969-981. doi: 10.1124/jpet.108.144568
124. Nakanishi, K., Yamada, J., Takayama, C., Oohira, A., and Fukuda, A. (2002). NKCC1 activity modulates formation of functional inhibitory synapses in cultured neocortical neurons. Synapse 61, 138-149. doi: 10.1002/syn.20352
125. A receptors which contain the a-5 subunit, in the elevated plus-maze test. Prog. Neu- ropsychopharmacol. Biol. Psychiatry 26, 1389-1392. doi: 10.1016/S0278- 5846(02)00305-6
126. Nusser, Z., and Mody, I. (2002). Selective modulation of tonic and phasic inhibitions in dentate gyrus granule cells. J. Neurophysiol. 87, 2624-2628.
127. A receptors to synaptic and extrasynaptic membranes of cerebellar granule cells. J. Neurosci. 18, 1693-1703.
128. Nutt, D. J., Besson, M., Wilson, S. J., Dawson, G. R., and Lingford- Hughes, A. R. (2007). Blockade of alcohol's amnestic activity in humans by an α5 subtype benzodiazepine receptor inverse agonist. Neuropharmacology 53,810-820. doi: 10.1016/j.neuropharm.2007.08.008
129. A receptor agonist THIP ameliorates specific behavioral deficits in the mouse model of fragile X syndrome. Dev. Neurosci. 33, 395-403. doi: 10.1159/000332884
130. Olmos-Serrano, J. L., Paluszkiewicz, S. M., Martin, B. S., Kaufmann, W. E., Corbin, J. G., and Huntsman, M. M. (2010). Defective GABAergic neurotransmission and pharmacological rescue of neuronal hyperexcitability in the amygdala in a mouse model of fragile X syndrome. J. Neurosci. 30, 9929-9938. doi: 10.1523/JNEUROSCI.1714-10. 2010
131. Olsen, R. W., and Sieghart, W. (2008). International union of pharmacology. LXX. Subtypes of y-aminobutyric acid A receptors: classification on the basis of subunit composition, pharmacology, and function. Update. Pharmacol. Rev. 60, 243-260. doi: 10.1124/pr.108.00505
132. Owens, D. F., Boyce, L. H., Davis, M. B., and Kriegstein, A. R. (1996). Excitatory GABA responses in embryonic and neonatal cortical slices demonstrated by gramicidin perforated-patch recordings and calcium imaging. J. Neurosci. 16, 6414-6423.
133. Owens, D. F., and Kriegstein, A. R. (2002). Is there more to GABA than synaptic inhibition? Nat. Rev. Neurosci. 3, 715-727. doi: 10.1038/nrn919
134. Perez-Cremades, D., Hernandez, S., Blasco-Ibanez, J. M., Crespo, C., Nacher, J., and Varea, E. (2010). Alteration of inhibitory circuits in the somatosensory cortex of Ts65Dn mice, a model for Down's syndrome. J. Neural. Transm. 117, 445-455. doi: 10.1007/s00702-010-0376-9
135. A receptors mediate phasic and tonic forms of inhibition in hippocampal pyramidal neurons. J. Neurophysiol. 96, 846-857.
136. A α5 receptors by RO4938581 attenuates discrete subchronic and early postnatal phencyclidine (PCP)-induced cognitive deficits in rats. Psychopharmacology 221, 451-468. doi: 10.1007/s00213- 011-2593-9
137. A receptors and tonic inhibition in rat auditory thalamus. PLoS ONE 6:e16508. doi: 10.1371/journal.pone.0016508
138. A receptor-mediated tonic inhibition in aged rat auditory thalamus. J. Neurosci. 33, 1218-1227. doi: 10.1523/JNEUROSCI.3277-12.2013
139. A receptor agonists in the rat spared nerve injury model of neuropathic pain. Eur. J. Pharmacol. 516, 131-138. doi: 10.1016/j.ejphar.2005.04.034
140. A receptor subunit expression and pharmacology in human Angelman syndrome cortex. Neurosci. Lett. 483, 167-172. doi: 10.1016/j.neulet.2010.08.001
141. Saab, B. J., MacLean, A. J., Kanisek, M., Zurek, A. A., Martin, L. J., Roder, J. C., et al. (2010). Short-term memory impairment after isoflu- rane in mice is prevented by the a5 y-aminobutyric acid type A receptor inverse agonist L-655,708. Anesthesiology 113, 1061-1071. doi: 10.1097/ALN.0b013e3181f56228
142. A receptors regulates receptor insertion and tonic current. EMBO J. 31, 2937-2951. doi: 10.1038/emboj.2012.109
143. Sall, J. W., Stratmann, G., Leong, J., McKleroy, W., Mason, D., Shenoy, S., et al. (2009). Isoflu- rane inhibits growth but does not cause cell death in hippocampal neural precursor cells grown in culture. Anesthesiology 110, 826-833. doi: 10.1097/ALN.0b013e31819b62e2
144. A receptor a6 subunit to phasic and tonic inhibition revealed by a naturally occurring polymorphism in the a6 gene. J. Neurosci. 26, 3357-3364. doi: 10.1523/JNEUROSCI.4799-05.2006
145. A receptors. J. Neurosci. 31, 18198-18210. doi: 10.1523/JNEUROSCI.2560-11.2011
146. Sato, M., and Stryker, M. P. (2010). Genomic imprinting of experience- dependent cortical plasticity by the ubiquitin ligase gene Ube3a. Proc. Natl. Acad. Sci. U.S.A. 107, 5611-5616. doi: 10.1073/pnas.10012 81107
147. Satomoto, M., Satoh, Y., Terui, K., Miyao, H., Takishima, K., Ito, M., et al. (2009). Neonatal exposure to sevoflurane induces abnormal social behaviors and deficits in fear conditioning in mice. Anesthesiology 110, 628-637. doi: 10.1097/ALN.0b013e3181974fa2
148. Saxena, N. C., and MacDonald, R. L. (1996). Properties of putative cerebellar γ-aminobutyric acid A receptor isoforms. Mol. Pharmacol. 49, 567-579.
149. A receptor-mediated currents in human brain. Eur. J. Neurosci. 24, 1157-1160. doi: 10.1111/j.1460- 9568.2006.04989.x
150. Semyanov, A., Walker, M. C., and Kull- mann, D. M. (2003). GABA uptake regulates cortical excitability via cell type-specific tonic inhibition. Nat. Neurosci. 6, 484-490.
151. A receptors triggers anxiety at puberty. Nat. Neurosci. 10, 469-477.
152. A receptor a4 subunit suppression prevents withdrawal properties of an endogenous steroid. Nature 392, 926-930. doi: 10.1038/31948
153. A conductance in hippocampal interneurons. Nat. Commun. 2, 376. doi: 10.1038/ncomms1377
154. Song, I., Volynski, K., Brenner, T., Ushkaryov, Y., Walker, M., and Semyanov, A. (2013). Different transporter systems regulate extracellular GABA from vesicular and non-vesicular sources. Front. Cell. Neurosci. 7:23. doi: 10.3389/fncel.2013.00023
155. A receptor subunits in the rat hippocampus I: immunocytochemical distribution of 13 subunits. Neuroscience 80, 987-1000. doi: 10.1016/S0306-4522(97) 00146-2
156. A receptors. Proc. Natl. Acad. Sci. U.S.A. 100, 14439-14444. doi: 10.1073/pnas.2435457100
157. Stratmann, G., Sall, J. W., May, L. D., Bell, J. S., Magnusson, K. R., Rau, V., et al. (2009). Isoflurane differentially affects neurogenesis and long-term neurocognitive function in 60-day-old and 7-day-old rats. Anesthesiology 110, 834-848. doi: 10.1097/ALN.0b013e31819c463d
158. Takayama, C., and Inoue, Y. (2005). Developmental expression of GABA transporter-1 and 3 during formation of the GABAergic synapses in the mouse cerebellar cortex. Brain Res. Dev. Brain Res. 158, 41-49. doi: 10.1016/j.devbrainres.2005.05.007
159. A receptors in mouse neurons. Neuropharmacology 63,469-479. doi: 10.1016/j.neuropharm.2012.04.023
160. Verkerk, A. J., Pieretti, M., Sutcliffe, J.S., Fu, Y. H., Kuhl, D. P., Pizzuti, A., et al. (1991). Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 65, 905-914. doi: 10.1016/0092-8674(91) 90397-H
161. Volk, D. W., Austin, M. C., Pierri, J. N., Sampson, A. R., and Lewis, D.A. (2000). Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical y-aminobutyric acid neurons in subjects with schizophrenia. Arch. Gen. Psychiatry 57, 237-245. doi: 10.1001/archpsyc.57.3.237
162. A receptors and increase tonic currents in thalamus. Neuropharmacology 56, 182-189. doi: 10.1016/j.neuropharm.2008.08.004
163. Walsh, C. A. (1999). Genetic malformations of the human cerebral cortex. Neuron 23, 19-29. doi: 10.1016/S0896-6273(00)80749-7
164. Wang, D. D., and Kriegstein, A. R. (2008). GABA regulates excitatory synapse formation in the neocortex via NMDA receptor activation. J. Neurosci. 28, 5547-5558. doi: 10.1523/JNEUROSCI.5599-07.2008
165. A receptors. Cell Rep. 2, 488-496. doi: 10.1016/j.celrep.2012.08.022
166. Wang, T., Kumada, T., Morishima, T., Iwata, S., Kaneko, T., Yanagawa, Y., et al. (2013). Accumulation of GABAergic neurons, causing a focal ambient GABA gradient, and down- regulation of KCC2 are induced during microgyrus formation in a mouse model of polymicrogyria. Cereb. Cortex doi: 10.1093/cercor/bhs375 [Epub ahead of print].
167. Weeber, E. J., Jiang, Y. H., Elgersma, Y., Varga, A. W., Carrasquillo, Y., Brown, S. E., et al. (2003). Derangements of hippocampal calcium/calmodulin- dependent protein kinase II in a mouse model for Angelman mental retardation syndrome. J. Neurosci. 23, 2634-2644.
168. A receptors and their activation by GABA spillover in the mouse dentate gyrus. J. Neurosci. 23, 10650-10661.
169. Wilson, I. A., Ikonen, S., Gallagher, M., Eichenbaum, H., and Tanila, H. (2005). Age-associated alterations of hippocampal place cells are subregion specific. J. Neurosci. 25, 6877-6886. doi: 10.1523/JNEUROSCI.1744-05.2005
170. A receptor a6 subunit in hippocampal pyramidal neurons produces extrasynaptic receptors and an increased tonic inhibition. Neuropharmacology 43, 530-549. doi: 10.1016/S0028-3908(02)00151-X
171. Wu, Y., Wang, W., and Richerson, G.B. (2003). Vigabatrin induces tonic inhibition via GABA transporter reversal without increasing vesicular GABA release. J. Neurophysiol. 89, 2021-2034. doi: 10.1152/jn.00856.2002
172. A receptor-mediated tonic inhibition in ratsomatosensorycortex. Cereb. Cortex 17, 1782-1787. doi: 10.1093/cer- cor/bhl087
173. - uptake promoting depolarizing GABA actions in immature rat neocortical neurones is mediated by NKCC1. J. Physiol. 557, 829-841. doi: 10.1113/jphysiol.2004. 062471
174. Yang, S., Weiner, B. D., Zhang, L. S., Cho, S. J., and Bao, S. (2011). Homeostatic plasticity drives tinnitus perception in an animal model. Proc. Natl. Acad. Sci. U.S.A. 108, 14974-14979. doi: 10.1073/pnas.1107998108
175. Yee, B. K., Hauser, J., Dolgov, V. V., Keist, R., Mohler, H., Rudolph, U., et al. (2004). GABA receptors containing the a5 subunit mediate the trace effect in aversive and appetitive conditioning and extinction of conditioned fear. Eur. J. Neurosci. 20, 1928-1936. doi: 10.1111/j.1460- 9568.2004.03642.x
176. Yoon, J. H., Maddock, R. J., Rokem, A., Silver, M. A., Minzenberg, M. J., Ragland, J. D., et al. (2010). GABA concentration is reduced in visual cortex in schizophrenia and correlates with orientation- specific surround suppression. J. Neurosci. 30, 3777-3781. doi: 10.1523/JNEUROSCI.6158-09.2010
177. Zorn, S. H., and Enna, S. J. (1985). The effect of mouse spinal cord transection on the antinociceptive response to the y-aminobutyric acid agonists THIP (4,5,6,7-tetrahydroisoxazolo [5,4-c]pyridine-3-ol) and baclofen. Brain Res. 338, 380-383. doi: 10.1016/0006-8993(85)90173-8
178. Zurek, A. A., Bridgwater, E. M., and Orser, B. A. (2012). Inhibition of a5 δ-aminobutyric acid type A receptors restores recognition memoryafter general anesthesia. Anesth. Analg. 114, 845-855. doi: 10.1213/ANE.0b013e31824720da